CMV in kidney transplantation: a single center experience over 22 years.

Björn Nashan(Medizinische Hochschule Hannover), Jürgen Klempnauer(Medizinische Hochschule Hannover), R. Brunkhorst(Klinikum Region Hannover), V Kliem, R Lück, H. J. Schlitt

PubMed

January 1, 1999

Cited by 11

Related Papers

Epidemiology of sepsis in Germany: results from a national prospective multicenter study

|Intensive Care Medicine|2007|623

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

|BMJ|2012|309

First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients

|Journal of the American Society of Nephrology|2002|274

Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: A prospective, randomized study

|Arthritis & Rheumatism|1998|261

Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study

|The Lancet|2001|256